Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT06246175 Recruiting - Type 2 Diabetes Clinical Trials

A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects

Start date: February 28, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess how fast HRS9531 gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.

NCT ID: NCT06243172 Recruiting - Type 2 Diabetes Clinical Trials

Determining Circadian Metabolic and Behavioural Rhythms in Patients With and Without Type 2 Diabetes

Cir-D-Brain
Start date: February 1, 2024
Phase:
Study type: Observational

The goal of the present clinical descriptive study is to characterize and quantify the potential hormonal chronobiological differences between individuals with type 2 diabetes (T2D) and healthy age and weight-matched controls as either circadian aligned or misaligned. The investigators hypothesize that individuals with T2D have a misaligned and different circadian rhythmicity of circadian biomarkers (melatonin and cortisol) than controls, and that this difference in turn is related to 24h hormonal fluctuations, behaviour, and metabolic-, cardiac-, and cognitive parameters. Participants will be asked to: - fill-out a diary on eating and sleeping habits for 30 days - wear an actigraphy and continuous glucose monitor for 10-14 days - stay overnight at the research facility, including continuous blood sampling and polysomnography

NCT ID: NCT06242808 Recruiting - Hypertension Clinical Trials

Medically Tailored Groceries and Food Resource Coaching

Start date: May 31, 2024
Phase: N/A
Study type: Interventional

Eating healthy foods can help people manage health problems, like Type 2 diabetes and heart disease. Many people want to eat healthier, but changing eating behaviors is hard. Patients don't always know what foods to eat for their health problems and are hesitant to try foods that may be unfamiliar. These challenges are made more difficult when families have lower incomes, which makes accessing healthy foods difficult and trying new foods riskier when on a budget. Food is Medicine programs connect people to healthy foods that help them manage health problems. One example is a medically tailored grocery program. This program provides a patient with free groceries selected to help their medical condition. For example, a patient receives fruits, vegetables, whole grains, and low-salt, low-sugar foods if they have high blood pressure. Food resource coaching is another strategy for eating healthy food. This approach provides a coach that supports learning healthy eating habits when facing financial challenges by using available food resources. Among other strategies, a coach may teach the participant how to meal plan and shop at nearby stores to increase healthy and delicious eating patterns. In our study, the investigators will ask lower-income patients with at least one chronic health problem at a safety-net clinic if they want to participate in a Food is Medicine program. Patients that want to participate will be randomly placed in one of two groups. One group will get medically tailored groceries and food resource coaching from a free food market for four months. The other group will get free food from the same market for four months, but food will not be medically tailored, and they will not meet with a coach. Participants will have the option to continue getting food from the market at the end of the study if they want to. This study will help us learn what patients think about Food is Medicine programs and how to best carry out these programs in the future. The study will also help us determine if providing medically tailored groceries and food resource coaching helps patients improve their diet. The investigators will use what is learned in this study to create a larger and longer program that can be provided in safety-net clinics throughout Dallas-Fort Worth. Our main goal is to build a sustainable and helpful program for patients that may not otherwise have access to healthy foods and eating habits that set the foundation for better health.

NCT ID: NCT06239506 Recruiting - Type 2 Diabetes Clinical Trials

Novel Brominated and Organophosphate Flame Retardants and Type 2 Diabetes

Start date: January 1, 2022
Phase:
Study type: Observational

As alternative flame retardants (FRs), novel brominated flame retardants (NBFRs) and organophosphate flame retardants (OPFRs) are ubiquitous in environment and may cause endocrine disruption effects. The associations between traditional endocrine-disrupting chemicals (EDCs) and type 2 diabetes have been extensively reported in epidemiological studies. To date, however, human-based evidence on the effects of NBFRs and OPFRs is lacking. The investigators conducted a case-control study of 344 participants aged 25-80 years from Shandong Province, East China, to assess potential associations between serum NBFR and OPFR concentrations and etiology of type 2 diabetes for the first time.

NCT ID: NCT06236581 Recruiting - Type 2 Diabetes Clinical Trials

Glycemic Excursion Minimization (GEM) to Outshine Health Disparities

GEM
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black young adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.

NCT ID: NCT06232746 Recruiting - Obesity Clinical Trials

Magnetic Jejuno-Ileal Diversion Study ("MJI Study")

Start date: February 13, 2024
Phase: N/A
Study type: Interventional

The purpose of this clinical research study is to evaluate the feasibility/performance, safety and initial efficacy of the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System (Magnet System, DI Biofragmentable and hereafter referred to as the DI Magnet System) for creation of a side-to-side jejuno-ileal anastomosis in adults with obesity and type 2 diabetes mellitus (T2DM).

NCT ID: NCT06224790 Recruiting - Type 2 Diabetes Clinical Trials

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

PenDaNt
Start date: March 10, 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effectiveness & safety of pirfenidone in type 2 diabetic patients with diabetic nephropathy

NCT ID: NCT06222086 Recruiting - Type 2 Diabetes Clinical Trials

The Effects of Calisthenic Exercise Training in Patients With Type 2 Diabetes

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

Type 2 diabetes (T2DM) is a metabolic disease characterized by chronic hyperglycemia that occurs as a result of any disorder in insulin secretion or insulin activity. Regular physical activity is important in preventing and managing this disease.

NCT ID: NCT06221969 Recruiting - Type 2 Diabetes Clinical Trials

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Start date: January 16, 2024
Phase: Phase 3
Study type: Interventional

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigational medicine. Doctors may not yet prescribe CagriSema. CagriSema will be compared to a medicine called tirzepatide that doctors may prescribe in some countries. Participants will get either CagriSema or tirzepatide. Which treatment participant get is decided by chance like flipping a coin. Participant will have an equal chance of receiving either drug. For each participant, the study will last for up to one and a half years.

NCT ID: NCT06202742 Recruiting - Type 2 Diabetes Clinical Trials

Cognitive Behavioral Therapy for Insomnia in Type 2 Diabetes Mellitus

Start date: March 8, 2024
Phase: N/A
Study type: Interventional

This study will explore the effects of cognitive behavioral therapy for insomnia (CBTI) compare to health educations in patients with type 2 diabetes (T2DM) with insomnia symptoms.